drugset / Trial / NCT01149304

Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity

NCT01149304

Phase 2 Completed 22 enrolled University of Magdeburg Sirtex Medical · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

To evaluate whether a combination regimen of pentoxifylline, ursodeoxycholic acid and enoxaparin provides a protective effect on the liver parenchyma after high dose rate (HDR) brachytherapy.

Timeline

Start
2009-06
Primary completion
2017-11-15
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified 40 mg Subcutaneous
Subject Pentoxifylline Small molecule 400 mg
Subject Ursodeoxycholic Acid Small molecule 250 mg